- Home
- TCMD vs QTRX Comparison
TCMD vs QTRX Comparison
Compare TCMD & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCMD
- QTRX
- Stock Information
- Founded
- TCMD 1995
- QTRX 2007
- Country
- TCMD United States
- QTRX United States
- Employees
- TCMD N/A
- QTRX N/A
- Industry
- TCMD Medical/Dental Instruments
- QTRX Biotechnology: Laboratory Analytical Instruments
- Sector
- TCMD Health Care
- QTRX Industrials
- Exchange
- TCMD Nasdaq
- QTRX Nasdaq
- Market Cap
- TCMD 427.6M
- QTRX 439.1M
- IPO Year
- TCMD 2016
- QTRX 2017
- Fundamental
- Price
- TCMD $17.40
- QTRX $8.87
- Analyst Decision
- TCMD Hold
- QTRX Strong Buy
- Analyst Count
- TCMD 1
- QTRX 4
- Target Price
- TCMD N/A
- QTRX $23.25
- AVG Volume (30 Days)
- TCMD 230.4K
- QTRX 786.7K
- Earning Date
- TCMD 02-18-2025
- QTRX 11-12-2024
- Dividend Yield
- TCMD N/A
- QTRX N/A
- EPS Growth
- TCMD N/A
- QTRX N/A
- EPS
- TCMD 0.65
- QTRX N/A
- Revenue
- TCMD $285,051,000.00
- QTRX $133,809,000.00
- Revenue This Year
- TCMD $8.83
- QTRX $13.79
- Revenue Next Year
- TCMD $9.86
- QTRX $15.34
- P/E Ratio
- TCMD $26.93
- QTRX N/A
- Revenue Growth
- TCMD 5.31
- QTRX 14.72
- 52 Week Low
- TCMD $11.12
- QTRX $8.21
- 52 Week High
- TCMD $21.10
- QTRX $29.70
- Technical
- Relative Strength Index (RSI)
- TCMD 50.55
- QTRX 34.59
- Support Level
- TCMD $17.13
- QTRX $8.21
- Resistance Level
- TCMD $17.89
- QTRX $10.39
- Average True Range (ATR)
- TCMD 0.61
- QTRX 0.87
- MACD
- TCMD -0.02
- QTRX -0.21
- Stochastic Oscillator
- TCMD 51.43
- QTRX 15.73
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
About QTRX Quanterix Corporation
Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory, Homebrew - Custom Assay Development, and Uman NF-Light.